title: Malignancies and cyclophosphamide exposure in Wegener's granulomatosis.
authors.forename: Sasha
authors.initials: S
authors.lastname: Bernatsky
authors.forename: Rosalind
authors.initials: R
authors.lastname: Ramsey-Goldman
authors.forename: Ann E
authors.initials: AE
authors.lastname: Clarke
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D009153:Mutagens / Q000009:adverse effects*; D009369:Neoplasms / Q000139:chemically induced*; D018570:Risk Assessment
chemical_list: D018501:Antirheumatic Agents; D009153:Mutagens; D003520:Cyclophosphamide